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CASE REPORT
relapse of Polymicrobial Endocarditis in an 
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Ruth W. Wang’ondua and Thomas S. Murrayb*
Departments of aCell Biology and bLaboratory Medicine and Pediatrics, Yale School of
Medicine, New Haven, Connecticut
A 26-year-old male intravenous drug user (IDU†) presented twice within 6 months with re-
lapsed polymicrobial infective endocarditis (IE) due to Eikenella corrodens and Streptococ-
cus constellatus after completing two courses of appropriate antimicrobial therapy. This
report points to relapsing endocarditis as a clinical entity that warrants attention in IDUs
when E. corrodens or S. constellatus are causative agents of IE. 
introduction
Intravenous drug users (IDUs) are at
increased  risk  for  infective  endocarditis
(IE)  with  tricuspid  valve  involvement
caused by a variety of organisms, including
Staphylococcus aureus, and both gram neg-
ative and/or gram positive oral flora [1].
The optimal treatment length for these pa-
tients is unknown, and some patients de-
velop  relapsing  endocarditis  despite
appropriate antimicrobial therapy [2-4]. We
report  an  instructive  case  of  relapsing
polymicrobial  endocarditis  in  an  IDU
whose blood originally grew only S. aureus
but later grew multiple fastidious organ-
isms once the S. aureus had been treated.
This case highlights: 1) the isolation of S.
aureus does not preclude the presence of
other organisms; 2) polymicrobial endo-
carditis is a risk for relapse, especially with
E. corrodens and S. constellatus, even with
prolonged antimicrobial therapy; 3) E. cor-
rodens and S. constellatus are synergistic
for infection in animal models, and this
may be relevant for human infections as
well; and 4) as urine toxicology screens do
not necessarily rule out active drug use, the
distinction between re-infection and relapse
can be difficult.
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A 26-year-old male presented to the
emergency department with a 2-week his-
tory of fevers, chills, myalgias, non-produc-
tive cough, episodes of non-bloody emesis,
and a 10- to 15-pound weight loss. He was a
habitual IV heroine user until a few months
prior to admission. He reported acquiring
syringes from pharmacies to inject heroine
mixed with tap water into both arms, denied
licking the needle before injecting heroine,
and denied reusing syringes. The patient ad-
mitted that he was on probation for 3 years
for a drug-related misdemeanor committed a
year before he presented. Conditions for his
probation included out-patient drug rehabil-
itation, which he reported completing a few
weeks  before  he  presented,  and  periodic
urine toxicology screens.
On admission, the patent was afebrile. A
2/6 systolic murmur at the left lower sternal
border (LLSB) was present on cardiac aus-
cultation, but the lung fields were clear. No
cutaneous abscesses, splinter hemorrhages,
or Osler’s nodes were appreciated. A urine
toxicology screen was not obtained upon ini-
tial presentation. Lab results included white
blood cell count 15, 100 cells/μL (82 percent
neutrophils),  positive  recombinant  im-
munoblot assay (RIBA) for hepatitis C virus
(HCV), and an undetectable HCV viral load
assayed by PCR. Hepatitis A, B, and HIV
serologies were negative. A chest CT of the
thorax showed bilateral scattered nodules,
some of which were cavitating, later pre-
sumed  to  be  septic  emboli.  A  trans-
esophageal echocardiogram demonstrated a
mobile 0.8 x 0.8-cm density on the tricuspid
valve with moderate tricuspid regurgitation
and mild pulmonary hypertension. Blood
cultures were drawn, and the patient was
treated empirically for endocarditis with van-
comycin and pipercillin/tazobactam.
Four out of four blood culture sets ob-
tained on the day of admission were positive
for methicillin-sensitive S. aureus. Two out
of four blood culture sets were positive for S.
constellatussusceptible to clindamycin, peni-
cillin (MIC of 0.094 µg/ml), ceftriaxone, and
vancomycin. The patient was given oxacillin
(2 g every 4 hours) and gentamicin (80 mg
every 8 hours), but his fevers persisted. Daily
blood cultures over the next 14 days grew
Prevotella intermedia, Eikenella corrodens,
and Hemophilus parainfluenzae (Figure 1).
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Figure 1. Summary of microbes in patient’s blood and course of antibiotic therapy.
The specific microorganisms isolated from the patient’s blood cultures and antibiotics dur-
ing each of his four hospitalizations denoted by Roman numerals I-IV are shown. The
number of hours to positivity for each organism isolated from each blood culture is indi-
cated on the top part of the cell. The number of bottles positive out of all bottles is shown
on the bottom part of the cell. His antibiotic regimen was changed to ceftri-
axone, metronidazole, and oxacillin. He im-
proved and completed 6 weeks of antibiotic
therapy administered by a home nursing serv-
ice via a peripherally inserted central catheter
(PICC). Blood cultures obtained 3 weeks
after  discharge  were  negative.  However,
blood cultures were not obtained after the pa-
tient completed the prescribed antibiotic reg-
imen. 
The patient was readmitted 6 weeks
after the completion of antibiotics with a
palpable, non-tender, 2 x 2 inch mass in the
right thigh, right hip pain that worsened with
joint  movement  and  weight  bearing,
malaise, fever, chills, night sweats, watery
diarrhea, nausea, and vomiting. Blood cul-
tures were again positive for E. corrodens
and S. constellatus. Bilateral hip MRIs with
and without intravenous contrast revealed a
linear tear of the anterior-superior labrum in
his right hip and a rim-enhancing fluid col-
lection in the left obturator internus muscle
that was sterile when an aspirate was cul-
tured. A trans-esophageal echocardiogram
revealed a 1.3 x 1.2 cm echodensity on the
anterior leaflet of the tricuspid valve and an
interval increase in degree of tricuspid re-
gurgitation. A  chest  CT  revealed  almost
complete resolution of the multiple pleura-
based cavitary lesions. The patient reported
that during the interval between his two hos-
pitalizations, he had been subject to periodic
urine toxicology screens that were negative
for opiates. A urine toxicology screen per-
formed when he presented was negative for
cocaine, oxycodone, opiates, barbiturates,
amphetamine, methadone, and phencycli-
dine and positive only for benzodiazepines.
The patient was treated with gentamicin (80
mg  every  8  hours)  and  ceftriaxone  (2  g
daily),  improved,  and  was  discharged  to
complete  2  weeks  of  gentamicin  and  6
weeks  of  ceftriaxone  administered  by  a
home nursing service via a PICC. Cultures
were negative after the patient completed his
second course of antibiotics.
He presented a third time 3 months later
(Figure 1) with a 7-day history of pleuritic
chest pain, fevers, chills, and night sweats. A
presumptive diagnosis of endocarditis was
given,  and  he  received  vancomycin  and
pipercillin/tazobactam, later changed to van-
comycin,  ceftriaxone,  and  gentamicin.  A
chest CT was concerning for septic emboli,
and a transthoracic echocardiogram showed
his vegetation was unchanged from previous
studies. Blood cultures on the day of presen-
tation were positive for S. constellatus sus-
ceptible  to  penicillin,  vancomycin,  and
ceftriaxone. On dental evaluation, poor oral
hygiene was noted. A diagnosis of relapsing
endocarditis was made, and the patient was
given 4 weeks of penicillin G (3 million units
every 4 hours) with 2 weeks of gentamicin
(100 mg every 8 hours). The patient im-
proved and was discharged but readmitted 10
days later with pleuritic right sided chest pain.
A chest X-ray showed a new area of opacifi-
cation in the right lower lobe. A CT scan of
the chest showed multiple areas of ground
glass opacification and consolidation involv-
ing the lower lobes, consistent with compli-
cated pneumonia. The patient was treated
with vancomycin and pipercillin/tazobactam,
later switched to ampicillin/sulbactam. Blood
cultures were positive only for Sphingomonas
paucimobilis. The patient responded to ther-
apy, discharged, and was not readmitted in
the following 6 months.
diScuSSion
A repeat episode of IE caused by the
same species within 6 months of the initial
episode is traditionally defined as a relapse,
whereas a repeat episode 6 months after the
initial episode is defined as recurrent IE or re-
infection [3-6]. IDU is a known risk factor for
recurrent or relapsing IE with incidences re-
ported as high as 41 percent [3]. While in this
case urine toxicology screens were negative,
continued intermittent drug use cannot be
conclusively eliminated as a cause of re-in-
fection rather than relapse. Urine immunoas-
says detect >300ng/ ml of 6-acetyl-morphine,
typically picking up drug use within 54 hours,
depending on dose of heroine. Active drug
use should always be considered when eval-
uating patients for a repeat episode of IE [7].
IDUs are also at increased risk for polymi-
crobial IE with rates in one series of 8 percent
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cause of IE in IDUs, its presence does not rule
out polymicrobial infection [8,9]. This case
illustrates how once the S. aureus is treated,
more fastidious organisms can be recovered
from the blood stream. Prevotella intermedia,
Hemophilus parainfluenzae, S. constellatus,
and E. corrodens are fastidious oral bacteria
that cause IE in IDUs after salivary contami-
nation of drug paraphernalia due to licking or
blowing into needles or licking injection sites
[10-14].
E. corrodensis often cultured with other
bacteria and when recovered should alert the
physician to the possibility of polymicrobial
IE. S. constellatus and E. corrodens IE are
enhanced by synergism between E. corro-
densand streptococci hypothesized to be due
to  coinciding  metabolic  niches  [15-17].
These organisms co-aggregate during in vitro
growth, and 76 percent of S. anginosusgroup
clinical isolates are recovered as part of a
mixed culture. In animal models, infections
result when E. corrodens is inoculated with
streptococci, but not when E. corrodensis in-
oculated alone [15-17]. E.corrodens is also
associated with clinical relapse as observed
for this patient. S. constellatus blood stream
infections are also a risk for embolic com-
plications as observed in this case. This re-
port demonstrates that physicians should be
alert for relapse and embolic complications
when E. corrodens and S. constellatus are
isolated together during IE, even if past ther-
apy was appropriate.
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